CIK 0001824893
- Non-accelerated filer
- Smaller reporting company
Surrozen, Inc./DE
Sign in to watch- Ticker
- SRZN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 301374889
- Phone
- +1 650-475-2820
- Business address
- 171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Consonance-HFW Acquisition Corp.
- 4/A Grant or award Director acquired 24,000 shares (grant or award)
- 4/A Open-market sale Director sold 90,000 shares at $0.01 ($981)
- 4/A Grant or award Director acquired 24,000 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 24,000 shares (grant or award)
- 4/A Open-market sale Chief Financial Officer sold 90,000 shares at $0.01 ($981)
- 4/A Grant or award Director acquired 24,000 shares (grant or award)
- 3/A Insider 3/A
- 3/A Insider 3/A
- 3/A Insider 3/A
- 3/A Insider 3/A
- 4 Open-market buy Director bought 1,000,000 shares
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 24,000 shares
- 4 Open-market buy 10% owner bought 24,000 shares
- 4 Open-market buy Director bought 24,000 shares
- 4 Open-market buy Chief Financial Officer bought 24,000 shares
- 4 Open-market buy Chief Financial Officer bought 410,000 shares
- 4 Open-market buy Director bought 410,000 shares
- 4 Open-market buy 10% owner bought 410,000 shares
- 4 Open-market buy Director bought 410,000 shares
Page 9 of 10 · 189 filings